You will move to an external webpage. Are you sure?
News & Press Release
2016-05-31Announcements
Nobelpharma signs license agreement with Danish Serendex Pharmaceuticals A/S for future commercialization of Molgradex®(inhaled GM-CSF therapy) for Pulmonary Alveolar Proteinosis in Japan
Nobelpharma signs license agreement with Danish Serendex Pharmaceuticals A/S for future commercialization of Molgradex®(inhaled GM-CSF therapy) for Pulmonary Alveolar Proteinosis in Japan